PIVA, Roberto
PIVA, Roberto
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors
2019-01-01 Valentina Audrito, Antonella Managò, Federica Gaudino, Ilaria Manfredonia, Vincenzo Gianluca Messana, Nicoletta Vitale, Lorenzo Brandimarte, Enrico Moiso, Roberto Piva, Nadia Raffaelli, Mario Mandalà, Silvia Deaglio
CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation
2005-01-01 Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G
CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma.
2025-01-01 Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva.
Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation
2007-01-01 Piva R; E Pellegrino; V Grosso; AD Manazza; F Boccalatte; V Poli; A Neri; R Chiarle; G Inghirami
Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity
2007-01-01 Piva R; Pellegrino E; Chiarle R; Manazza AD; Boccalatte F; Neri A; Levy DE; Inghirami G
Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma
2022-01-01 María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva
Gene expression profiling uncovers molecular classifiers for the recognition of Anaplastic Large Cell Lymphoma within Peripheral T-cell neoplasms
2009-01-01 Piva R; Pellegrino E; Agnelli L; Neri A; Inghirami G
Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma
2024-01-01 Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva.
Genomic and functional approaches as powerful tools to stratify human T-cell lymphoproliferative disorders and to identify relevant tumorigenic culprits
2008-01-01 Piva R, Pellegrino E, Agnelli L, Grosso V, Tamagno I, Ferrantino L, Cagnoni G, Fornari A; Novero D; Poli V, Zamò A, Chiosi M, Rosenwald A, Müller-Hermelink HK, Vermi W, Facchetti F, Fulciniti F, De Chiara A, Ponzoni M, Doglioni C, Piccaluga PP, Pileri S, De Wolf-Peeters C, Neri A, Inghirami G
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA
2005-01-01 R Piva; E Pellegrino; M Mattioli; C Voena; C Conte; F Boccalatte; C Ambrogio; A Manazza; A Neri; R Chiarle; G Inghirami
Identification of molecular classifiers and key signalling networks in T-cell lymphoproliferative disorders through gene expression profiling meta-analyses
2011-01-01 Piva R; Limongi T; Agnelli L; Pellegrino E; Neri A; Iqbal J; Piccaluga PP; Pileri S; Kwee I; Bertoni F; Chen WC; Inghirami G
Isolation and characterization of sphere-forming cells from a gliosarcoma patient
2009-01-01 Tamagno I; Senetta R; Bozzaro M; Fontanella M; Piva R; Cassoni P
LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies
2022-01-01 Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva
Molecular anatomy of peripheral T cell lymphomas
2009-01-01 Pellegrino E, Agnelli L, Todoerti K, Fornari A, Novero D; Cuccuru G, Ferreri C, Martinoglio B, Medico E, Zamò A, Facchetti F, De Chiara A, Ponzoni M, Rosenwald A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G, Piva R
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22
2016-01-01 Arruga, F; Gizdic, B; Bologna, C; Cignetto, S; Buonincontri, R; Serra, S; Vaisitti, T; Vitale, N; Garaffo, G; Mereu, E; Diop, F; Neri, F; Coscia, M; Allan, JN; Piva, R; Oliviero, S; Furman, RR; Rossi, D; Gaidano, G; Deaglio, S
Network-based inference of ALK oncogenic signaling in T-cell lymphoproliferative disorders
2010-01-01 Piva R; Pellegrino E; Agnelli L; Cantarella D; Ferreri C; Ferracin M; Cuccuru G; Voena C; Provero P; Negrini M; Di Cunto F; Neri A; Medico E; Inghirami G
Network-based inference of tumorogenic culprits in human T-cell lymphoproliferative disorders
2008-01-01 Piva R; Pellegrino E; Agnelli A; Tamagno I; Vallania F; Poli V; Medico E; Chatr-aryamontri A; Rosenwald A; Muller-Hermelink HK; Piccaluga PP; Pileri S; De Wolf-Peeters C; Neri A; Inghirami G
p27/Kip.1 ubiquitin ligase subunit skp2 relationships with cell proliferation and p27/Kip.1 expression in gliomas
2001-01-01 Schiffer, D.; Cavalla, P.; Fiano, V.; Vercellino, M.; Piva, R.; Pagano, M.
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human Anaplastic Large Cell Lymphoma cells
2004-01-01 Piva R; Manazza AD; Taulli R; Ponzetto C; Chiarle R; Inghirami G
Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human anaplastic large cell lymphoma cells
2005-01-01 Piva R; Manazza A; Taulli R; Ponzetto C; Simmons W; Chiarle R; Inghirami G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors | 2019 | Valentina Audrito, Antonella Managò, Federica Gaudino, Ilaria Manfredonia, Vincenzo Gianluca Messana, Nicoletta Vitale, Lorenzo Brandimarte, Enrico Moiso, Roberto Piva, Nadia Raffaelli, Mario Mandalà, Silvia Deaglio | |
| CD30 expression in anaplastic large cell lymphomas is dependent on ALK tyrosine kinase activity via Stat3 phosphorylation and JunB upregulation | 2005 | Boccalatte F; Piva R; Manazza A; Palestro G; Chiarle R; Inghirami G | |
| CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma. | 2025 | Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva. | |
| Dissection of critical pathways instrumental for Anaplastic Lymphoma Kinase transformation | 2007 | Piva R; E Pellegrino; V Grosso; AD Manazza; F Boccalatte; V Poli; A Neri; R Chiarle; G Inghirami | |
| Dissection of critical pathways instrumental to the Anaplastic Lymphoma Kinase oncogenic activity | 2007 | Piva R; Pellegrino E; Chiarle R; Manazza AD; Boccalatte F; Neri A; Levy DE; Inghirami G | |
| Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma | 2022 | María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva | |
| Gene expression profiling uncovers molecular classifiers for the recognition of Anaplastic Large Cell Lymphoma within Peripheral T-cell neoplasms | 2009 | Piva R; Pellegrino E; Agnelli L; Neri A; Inghirami G | |
| Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma | 2024 | Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva. | |
| Genomic and functional approaches as powerful tools to stratify human T-cell lymphoproliferative disorders and to identify relevant tumorigenic culprits | 2008 | Piva R, Pellegrino E, Agnelli L, Grosso V, Tamagno I, Ferrantino L, Cagnoni G, Fornari A; Novero D; Poli V, Zamò A, Chiosi M, Rosenwald A, Müller-Hermelink HK, Vermi W, Facchetti F, Fulciniti F, De Chiara A, Ponzoni M, Doglioni C, Piccaluga PP, Pileri S, De Wolf-Peeters C, Neri A, Inghirami G | |
| Identification of genomic and proteomic signatures in lymphomas by inducible shRNA | 2005 | R Piva; E Pellegrino; M Mattioli; C Voena; C Conte; F Boccalatte; C Ambrogio; A Manazza; A Neri; R Chiarle; G Inghirami | |
| Identification of molecular classifiers and key signalling networks in T-cell lymphoproliferative disorders through gene expression profiling meta-analyses | 2011 | Piva R; Limongi T; Agnelli L; Pellegrino E; Neri A; Iqbal J; Piccaluga PP; Pileri S; Kwee I; Bertoni F; Chen WC; Inghirami G | |
| Isolation and characterization of sphere-forming cells from a gliosarcoma patient | 2009 | Tamagno I; Senetta R; Bozzaro M; Fontanella M; Piva R; Cassoni P | |
| LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies | 2022 | Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva | |
| Molecular anatomy of peripheral T cell lymphomas | 2009 | Pellegrino E, Agnelli L, Todoerti K, Fornari A, Novero D; Cuccuru G, Ferreri C, Martinoglio B, Medico E, Zamò A, Facchetti F, De Chiara A, Ponzoni M, Rosenwald A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S, Neri A, Inghirami G, Piva R | |
| Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 | 2016 | Arruga, F; Gizdic, B; Bologna, C; Cignetto, S; Buonincontri, R; Serra, S; Vaisitti, T; Vitale, N; Garaffo, G; Mereu, E; Diop, F; Neri, F; Coscia, M; Allan, JN; Piva, R; Oliviero, S; Furman, RR; Rossi, D; Gaidano, G; Deaglio, S | |
| Network-based inference of ALK oncogenic signaling in T-cell lymphoproliferative disorders | 2010 | Piva R; Pellegrino E; Agnelli L; Cantarella D; Ferreri C; Ferracin M; Cuccuru G; Voena C; Provero P; Negrini M; Di Cunto F; Neri A; Medico E; Inghirami G | |
| Network-based inference of tumorogenic culprits in human T-cell lymphoproliferative disorders | 2008 | Piva R; Pellegrino E; Agnelli A; Tamagno I; Vallania F; Poli V; Medico E; Chatr-aryamontri A; Rosenwald A; Muller-Hermelink HK; Piccaluga PP; Pileri S; De Wolf-Peeters C; Neri A; Inghirami G | |
| p27/Kip.1 ubiquitin ligase subunit skp2 relationships with cell proliferation and p27/Kip.1 expression in gliomas | 2001 | Schiffer, D.; Cavalla, P.; Fiano, V.; Vercellino, M.; Piva, R.; Pagano, M. | |
| Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human Anaplastic Large Cell Lymphoma cells | 2004 | Piva R; Manazza AD; Taulli R; Ponzetto C; Chiarle R; Inghirami G | |
| Targeting oncogenic ALK by lentiviral small interfering RNA induces growth arrest and apoptosis of human anaplastic large cell lymphoma cells | 2005 | Piva R; Manazza A; Taulli R; Ponzetto C; Simmons W; Chiarle R; Inghirami G |